EdgarLookup

Keros Therapeutics, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Knowles Julius Sale 2,267 $40.06 $90,816 450,845 Oct 1, 2021
Knowles Julius Sale 17,854 $40.51 $723,266 327,731 Sep 27, 2021
Lachey Jennifer Chief Scientific Officer Option Exercise 1,293 $0.30 $388 85,700 Aug 17, 2021
Knowles Julius Sale 30 $42.75 $1,283 354,987 Jul 1, 2021
Lachey Jennifer Chief Scientific Officer Option Exercise 6,500 $0.30 $1,950 84,407 Jun 24, 2021
Lachey Jennifer Chief Scientific Officer Option Exercise 2,650 $0.30 $795 80,557 Jun 11, 2021
Ordonez Claudia Chief Medical Officer Sale 347 $51.95 $18,027 Jun 11, 2021
Knowles Julius Sale 560 $51.46 $28,818 364,395 Jun 7, 2021
Knowles Julius Sale 91 $51.45 $4,682 375,175 Jun 3, 2021
Ordonez Claudia Chief Medical Officer Option Exercise 1,000 $0.48 $480 1,000 May 11, 2021
Lachey Jennifer Chief Scientific Officer Option Exercise 500 $0.30 $150 77,907 May 11, 2021
Knowles Julius Sale 3,509 $56.04 $196,644 398,506 May 3, 2021
Ordonez Claudia Chief Medical Officer Sale 400 $59.09 $23,636 600 Apr 12, 2021
Lachey Jennifer Chief Scientific Officer Sale 3,473 $59.99 $208,345 72,016 Apr 12, 2021
Knowles Julius Sale 2,402 $59.10 $141,958 402,050 Apr 6, 2021
Knowles Julius Sale 2,472 $58.42 $144,414 418,353 Apr 1, 2021
Lachey Jennifer Chief Scientific Officer Option Exercise 9,996 $0.11 $1,100 71,187 Apr 1, 2021
Ordonez Claudia Chief Medical Officer Sale 395 $64.09 $25,316 605 Mar 11, 2021
Lachey Jennifer Chief Scientific Officer Sale 4 $65.47 $262 61,191 Mar 11, 2021
Knowles Julius Sale 193 $58.03 $11,200 629,987 Mar 4, 2021
Knowles Julius Sale 1,473 $62.11 $91,488 437,111 Mar 2, 2021
Lachey Jennifer Chief Scientific Officer Option Exercise 33,200 $0.11 $3,652 61,191 Feb 26, 2021
Knowles Julius Sale 1,014 $59.34 $60,171 674,467 Feb 17, 2021
Knowles Julius Sale 531 $63.14 $33,527 450,960 Feb 12, 2021
Ordonez Claudia Chief Medical Officer Sale 2 $68.05 $136 Feb 11, 2021
Lachey Jennifer Chief Scientific Officer Sale 14 $68.05 $953 27,991 Feb 11, 2021
Pontifax Late Stage Fund L.P. Purchase 26,634 $50.00 $1,331,700 2,288,151 Nov 17, 2020
Pontifax (China) IV L.P. Purchase 6,000 $50.00 $300,000 155,262 Nov 17, 2020
Pontifax (Israel) IV, L.P. Purchase 12,966 $50.00 $648,300 1,122,768 Nov 17, 2020
GORDON CARL L Purchase 375,200 $16.00 $6,003,200 1,119,812 Apr 13, 2020
Kariv Tomer Purchase 194,203 $16.00 $3,107,248 2,261,517 Apr 13, 2020
Knowles Julius C 137,308 413,766 Apr 13, 2020
Lazarus Alon Purchase 120,000 $16.00 $1,920,000 2,013,102 Apr 13, 2020
Nussbaum Ran Purchase 94,546 $16.00 $1,512,736 1,109,802 Apr 13, 2020
OrbiMed Capital GP VII LLC C 148,922 148,922 Apr 13, 2020
Pontifax Late Stage Fund L.P. Purchase 105,000 $16.00 $1,680,000 1,213,926 Apr 13, 2020
Seehra Jasbir Chief Executive Officer Purchase 20,000 $16.00 $320,000 243,856 Apr 13, 2020
Arkin Bio Venture Partners Ltd. C 1,382,295 1,382,295 Apr 13, 2020
Knowles Julius Purchase 1,191 $20.98 $24,987 1,191 Apr 13, 2020